There is no evidence Japan has named the COVID-19 vaccine the “most deadly drug in history,” as the post claims.

GSK said on Friday that its respiratory syncytial virus (RSV) vaccine has received approval in Japan for expanded use in ...

The World Health Organization listed KM Biologics' mpox vaccine for emergency use on Tuesday, making it the second shot to ...

The World Health Organization has permitted emergency use of a Japanese vaccine to inoculate against mpox, previously known ...

The listing from the World Health Organization paves the way for countries worldwide to quickly approve and import the ...

The World Health Organisation (WHO) has granted emergency use listing (EUL) for the LC16m8 mpox vaccine. This would be the ...

Largest donation so far, Japan to donate 3.05M doses of LC16m8 vaccine produced by KM Biologics - Anadolu Ajansı ...

GSK plc announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved a regulatory application to extend the indication of Arexvy (respiratory syncytial virus vaccine, recombinant ...

In September, after facing criticism for moving too slowly on vaccines, the agency cleared Bavarian Nordic's vaccine for mpox and said it was considering LC16, made by Japan's KM Biologics ...

Nov 22 (Reuters) - GSK (GSK.L), opens new tab said on Friday that its respiratory syncytial virus (RSV) vaccine has received approval in Japan for expanded use in adults aged between 50 and 59 ...